Delivery Order SPE2DU25D2017-SPE2DU26FAD56
- Not listed
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a $14,257.39 firm fixed-price delivery order to AmerisourceBergen Drug Corp on October 20, 2025, with completion expected by October 21, 2025. This non-competitive delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The delivery order is to be performed at AmerisourceBergen's corporate...
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $40,413.57 to AmerisourceBergen Drug Corp on January 5, 2026, with an ultimate completion date of January 6, 2026. This firm fixed price delivery order, issued under contract number 4570403734, requires performance at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The award was made competitively with no set-aside designation, reflecting the contractor's established capability to...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $14,073.00 to AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, on January 7, 2026. This firm fixed-price delivery order, designated as a non-set-aside competitive award, is scheduled for ultimate completion on January 8, 2026, with performance taking place at the awardee's corporate office location in Conshohocken, PA. AmerisourceBergen Drug Corp operates as a...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $4,523.20 on January 6, 2026, with an ultimate completion date of January 7, 2026. This non-set-aside contract utilizes firm fixed pricing and is funded through the Defense Logistics Agency's Medical Supply Chain, a defense agency program. The delivery order represents a child contract under AmerisourceBergen's parent company, Cencora, Inc., which...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on January 2, 2026, for pharmaceutical and medical supplies with a ceiling value of $5,936.04 and an ultimate completion date of January 5, 2026. This competitive award carries firm fixed pricing and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $369,718.44 to AmerisourceBergen Drug Corp on November 3, 2025, with an ultimate completion date of November 4, 2025. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), which is valued at $999,999,999.00 and extends through December 2026. The delivery...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,062.47 to AmerisourceBergen Drug Corp on October 20, 2025, with an ultimate completion date of October 21, 2025. This contract is a firm fixed price delivery order with no set-aside designation, meaning it was competitively awarded. The place of performance is located in Conshohocken, Pennsylvania, which is also the headquarters of the prime contractor. This delivery order represents a child contract under AmerisourceBergen...
- The Defense Logistics Agency awarded a delivery order valued at $4,838.33 to AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, on January 8, 2026, with an ultimate completion date of January 9, 2026. This firm fixed-price delivery order was competitively awarded with no set-aside designation and represents a task order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The parent company,...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $4,216.30 to AmerisourceBergen Drug Corp on July 28, 2025, with an ultimate completion date of July 29, 2025. This firm fixed-price, non-set-aside contract is a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The award represents a pharmaceutical delivery to be...
- The Defense Logistics Agency awarded a delivery order contract valued at $5,452.47 to AmerisourceBergen Drug Corp on December 3, 2025, with an ultimate completion date of December 4, 2025. This firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The contract was competitively awarded with no set-aside designation. The...
- SPE2DU25D2017Indefinite Delivery Contract
- SPE2DU25D2017-SPE2DU26FAD56Delivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,312.12 to AmerisourceBergen Drug Corp on January 9, 2026, with an ultimate completion date of January 12, 2026. This firm fixed-price delivery order, issued without set-aside designation, represents a child contract under the parent entity Cencora, Inc. (doing business as AmerisourceBergen). The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters as a major pharmaceutical distributor and critical vendor for federal medical procurement. This delivery order is executed under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 2026. The IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a vast range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including specialty medications, brand-name and generic drugs, vaccines, and medical devices across multiple therapeutic domains. The contract supports federal customers including the Defense Health Agency and U.S. Coast Guard, with AmerisourceBergen demonstrating substantial capability to fulfill government requirements through consistent competitive awards and efficient delivery of essential medical commodities to military treatment facilities and veterans' healthcare programs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.3k | 1/8/26 |